Next Generation Cardiovascular Drug Development Summit

Kongressthemen
Are you up to date on the latest research and developments in novel biologics to enhance regenerative and precision cardiovascular therapeutics?

Don't miss the Next Generation Cardiovascular Drug Development Summit, coming to Boston on April 25-27 as the only industry-focused meeting dedicated to leveraging novel cell and gene therapies using mRNA, CRISPR/Cas9 and iPSCs for cardiovascular disease.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
URL:
Brochure: https://go.evvnt.com/1492007-0?pid=4832

Speakers: Christopher O'Donnell, Global Head Cardiovascular and Metabolism Translational Medicine, Novartis Institutes of Biomedical Research, and more.

https://go.evvnt.com/1492007-1?pid=4832

Frau Nina Podmore